{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:16:40Z","timestamp":1792783000105,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Institute of Eminence, Banaras Hindu University, Varanasi, INDIA","award":["IoE\/MPDF\/2020-2021\/02"],"award-info":[{"award-number":["IoE\/MPDF\/2020-2021\/02"]}],"id":[{"id":"https:\/\/ror.org\/04cdn2797","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Institute of Eminence, University of Delhi, Delhi","award":["IoE 2023-24\/12\/FRP"],"award-info":[{"award-number":["IoE 2023-24\/12\/FRP"]}],"id":[{"id":"https:\/\/ror.org\/04gzb2213","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Institute of Eminence, Banaras Hindu University","award":["CRG\/2018\/003340"],"award-info":[{"award-number":["CRG\/2018\/003340"]}],"id":[{"id":"https:\/\/ror.org\/04cdn2797","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00210-024-03632-4","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T06:26:03Z","timestamp":1733379963000},"page":"6031-6041","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-diabetic drug pioglitazone reduces Islet amyloid aggregation overload in the Drosophila neuronal cells"],"prefix":"10.1007","volume":"398","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2278-3635","authenticated-orcid":false,"given":"Khushboo","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1085-3990","authenticated-orcid":false,"given":"Pooja","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4681-2691","authenticated-orcid":false,"given":"Shashank Kumar","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5050-4624","authenticated-orcid":false,"given":"Madhu G.","family":"Tapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"issue":"8","key":"3632_CR1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.febslet.2013.01.017","volume":"587","author":"A Abedini","year":"2013","unstructured":"Abedini A, Schmidt AM (2013) Mechanisms of islet amyloidosis toxicity in type 2 diabetes. FEBS Lett 587(8):1119\u20131127. https:\/\/doi.org\/10.1016\/j.febslet.2013.01.017","journal-title":"FEBS Lett"},{"key":"3632_CR2","doi-asserted-by":"publisher","first-page":"W530","DOI":"10.1093\/nar\/gkab294","volume":"94","author":"MF Adasme","year":"2021","unstructured":"Adasme MF et al (2021) PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA. Nucleic Acids Res 94:W530\u2013W534","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"3632_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nm.3159","volume":"19","author":"M Ahmadian","year":"2013","unstructured":"Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, Evans RM (2013) PPAR\u03b3 signaling and metabolism: the good, the bad and the future. Nat Med 19(5):557\u2013566. https:\/\/doi.org\/10.1038\/nm.3159","journal-title":"Nat Med"},{"key":"3632_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1476-5381.2011.01525.x","volume":"166","author":"J Barwell","year":"2012","unstructured":"Barwell J, Gingell JJ, Watkins HA, Archbold JK, Poyner DR, Hay DL (2012) Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs? Br J Pharmacol 166:51\u201365. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01525.x","journal-title":"Br J Pharmacol"},{"issue":"2","key":"3632_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1515\/hsz-2020-0174","volume":"402","author":"AK Bishoyi","year":"2020","unstructured":"Bishoyi AK, Roham PH, Rachineni K, Save S, Hazari MA, Sharma S, Kumar A (2020) Human islet amyloid polypeptide (hIAPP) - a curse in type II diabetes mellitus: insights from structure and toxicity studies. Biol Chem 402(2):133\u2013153. https:\/\/doi.org\/10.1515\/hsz-2020-0174","journal-title":"Biol Chem"},{"issue":"2","key":"3632_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1242\/dev.118.2.401","volume":"118","author":"AH Brand","year":"1993","unstructured":"Brand AH, Perrimon N (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development (Cambridge, England) 118(2):401\u2013415. https:\/\/doi.org\/10.1242\/dev.118.2.401","journal-title":"Development (Cambridge, England)"},{"issue":"7","key":"3632_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1474-4422(21)00043-0","volume":"20","author":"DK Burns","year":"2021","unstructured":"Burns DK, Alexander RC, Welsh-Bohmer KA, Culp M, Chiang C, O\u2019Neil J, Evans RM, Harrigan P, Plassman BL, Burke JR, Wu J, Lutz MW, Haneline S, Schwarz AJ, Schneider LS, Yaffe K, Saunders AM, Ratti E, TOMMORROW study investigators (2021) Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer\u2019s disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 20(7):537\u2013547. https:\/\/doi.org\/10.1016\/S1474-4422(21)00043-0","journal-title":"Lancet Neurol."},{"issue":"10","key":"3632_CR8","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s00125-022-05756-9","volume":"65","author":"JJ Castillo","year":"2022","unstructured":"Castillo JJ, Aplin AC, Hackney DJ, Hogan MF, Esser N, Templin AT, Akter R, Kahn SE, Raleigh DP, Zraika S, Hull RL (2022) Islet amyloid polypeptide aggregation exerts cytotoxic and proinflammatory effects on the islet vasculature in mice. Diabetologia 65(10):1687\u20131700. https:\/\/doi.org\/10.1007\/s00125-022-05756-9","journal-title":"Diabetologia"},{"issue":"5","key":"3632_CR9","doi-asserted-by":"publisher","first-page":"9000","DOI":"10.1038\/srep09000","volume":"11","author":"KL Chang","year":"2015","unstructured":"Chang KL, Pee HN, Yang S, Ho PC (2015) Influence of drug transporters and stereoselectivity on the brain penetration of pioglitazone as a potential medicine against Alzheimer\u2019s disease. Sci Rep 11(5):9000. https:\/\/doi.org\/10.1038\/srep09000","journal-title":"Sci Rep"},{"key":"3632_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fendo.2017.00006","volume":"8","author":"A Chaudhury","year":"2017","unstructured":"Chaudhury A, Duvoor C, Reddy Dendi VS, Kraleti S, Chada A, Ravilla R, Marco A, Shekhawat NS, Montales MT, Kuriakose K, Sasapu A, Beebe A, Patil N, Musham CK, Lohani GP, Mirza W (2017) Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management. Front Endocrinol 8:6. https:\/\/doi.org\/10.3389\/fendo.2017.00006","journal-title":"Front Endocrinol"},{"issue":"6","key":"3632_CR11","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jdiacomp.2017.01.006","volume":"31","author":"PS Chou","year":"2017","unstructured":"Chou PS, Ho BL, Yang YH (2017) Effects of pioglitazone on the incidence of dementia in patients with diabetes. J Diabetes Complications 31(6):1053\u20131057. https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.01.006","journal-title":"J Diabetes Complications"},{"key":"3632_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12860-020-00294-x","volume":"21","author":"ED Drew","year":"2020","unstructured":"Drew ED, Janes RW (2020) Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity. BMC Mol and Cell Biol 21:49. https:\/\/doi.org\/10.1186\/s12860-020-00294-x","journal-title":"BMC Mol and Cell Biol"},{"issue":"7","key":"3632_CR13","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1073\/pnas.0230450100","volume":"100","author":"W Farris","year":"2003","unstructured":"Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A 100(7):4162\u20137. https:\/\/doi.org\/10.1073\/pnas.0230450100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1 Suppl","key":"3632_CR14","doi-asserted-by":"publisher","first-page":"47S","DOI":"10.1177\/0145721715607642","volume":"41","author":"L Hieronymus","year":"2015","unstructured":"Hieronymus L, Griffin S (2015) Role of amylin in type 1 and type 2 diabetes. Diabetes Educ 41(1 Suppl):47S-56S. https:\/\/doi.org\/10.1177\/0145721715607642","journal-title":"Diabetes Educ"},{"issue":"9","key":"3632_CR15","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1210\/en.2016-1410","volume":"157","author":"MF Hogan","year":"2016","unstructured":"Hogan MF, Meier DT, Zraika S et al (2016) Inhibition of insulin-degrading enzyme does not increase islet amyloid deposition in vitro. Endocrinology 157(9):3462\u20133468. https:\/\/doi.org\/10.1210\/en.2016-1410","journal-title":"Endocrinology"},{"issue":"6","key":"3632_CR16","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10522-007-9105-7","volume":"8","author":"M Jafari","year":"2007","unstructured":"Jafari M, Khodayari B, Felgner J, Bussel II, Rose MR, Mueller LD (2007) Pioglitazone: an anti-diabetic compound with anti-aging properties. Biogerontology 8(6):639\u2013651. https:\/\/doi.org\/10.1007\/s10522-007-9105-7","journal-title":"Biogerontology"},{"issue":"3","key":"3632_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1006\/jmbi.2001.4593","volume":"308","author":"ET Jaikaran","year":"2001","unstructured":"Jaikaran ET, Higham CE, Serpell LC, Zurdo J, Gross M, Clark A, Fraser PE (2001) Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. J Mol Biol 308(3):515\u2013525. https:\/\/doi.org\/10.1006\/jmbi.2001.4593","journal-title":"J Mol Biol"},{"issue":"2","key":"3632_CR18","doi-asserted-by":"publisher","first-page":"E278","DOI":"10.1152\/ajpendo.00388.2009","volume":"298","author":"Y Kanda","year":"2010","unstructured":"Kanda Y, Shimoda M, Hamamoto S, Tawaramoto K, Kawasaki F, Hashiramoto M, Nakashima K, Matsuki M, Kaku K (2010) Molecular mechanism by which pioglitazone preserves pancreatic beta-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARgamma agonist. Am J Physiol Endocrinol Metab 298(2):E278\u2013E286. https:\/\/doi.org\/10.1152\/ajpendo.00388.2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"3632_CR19","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1172\/JCI69625","volume":"124","author":"J Kim","year":"2014","unstructured":"Kim J, Cheon H, Jeong YT, Quan W, Kim KH, Cho JM, Lim YM, Oh SH, Jin SM, Kim JH, Lee MK, Kim S, Komatsu M, Kang SW, Lee MS (2014) Amyloidogenic peptide oligomer accumulation in autophagy-deficient \u03b2 cells induces diabetes. J Clin Investig 124(8):3311\u20133324. https:\/\/doi.org\/10.1172\/JCI69625","journal-title":"J Clin Investig"},{"issue":"3","key":"3632_CR20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","volume":"166","author":"AJ King","year":"2012","unstructured":"King AJ (2012) The use of animal models in diabetes research. Br J Pharmacol 166(3):877\u2013894. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.01911.x","journal-title":"Br J Pharmacol"},{"key":"3632_CR21","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB (2011) LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 51:2778\u20132786","journal-title":"J Chem Inf Model"},{"issue":"1","key":"3632_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11605-018-4004-6","volume":"23","author":"S Li","year":"2019","unstructured":"Li S, Ghoshal S, Sojoodi M, Arora G, Masia R, Erstad DJ, Lanuti M, Hoshida Y, Baumert TF, Tanabe KK, Fuchs BC (2019) Pioglitazone reduces hepatocellular carcinoma development in two rodent models of cirrhosis. J Gastrointest Sur 23(1):101\u2013111. https:\/\/doi.org\/10.1007\/s11605-018-4004-6","journal-title":"J Gastrointest Sur"},{"issue":"4","key":"3632_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/aps.2013.11","volume":"34","author":"LP Liu","year":"2013","unstructured":"Liu LP, Yan TH, Jiang LY, Hu W, Hu M, Wang C, Zhang Q, Long Y, Wang JQ, Li YQ, Hu M, Hong H (2013) Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain \u03b2-amyloid through PPAR\u03b3 activation. Acta Pharmacol Sin 34(4):455\u2013463. https:\/\/doi.org\/10.1038\/aps.2013.11","journal-title":"Acta Pharmacol Sin"},{"issue":"45","key":"3632_CR24","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1021\/acs.biochem.9b00696","volume":"58","author":"K Long","year":"2019","unstructured":"Long K, Williams TL, Urbanc B (2019) Insulin inhibits A\u03b242 aggregation and prevents A\u03b242-induced membrane disruption. Biochemistry 58(45):4519\u20134529. https:\/\/doi.org\/10.1021\/acs.biochem.9b00696","journal-title":"Biochemistry"},{"issue":"7","key":"3632_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/aje\/154.7.635","volume":"154","author":"JA Luchsinger","year":"2001","unstructured":"Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R (2001) Diabetes mellitus and risk of Alzheimer\u2019s disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 154(7):635\u2013641. https:\/\/doi.org\/10.1093\/aje\/154.7.635","journal-title":"Am J Epidemiol"},{"key":"3632_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fnins.2015.00216","volume":"9","author":"TA Lutz","year":"2015","unstructured":"Lutz TA, Meyer U (2015) Amylin at the interface between metabolic and neurodegenerative disorders. Front Neurosci 9:216. https:\/\/doi.org\/10.3389\/fnins.2015.00216. (Published 2015 Jun 16)","journal-title":"Front Neurosci"},{"issue":"5","key":"3632_CR27","doi-asserted-by":"publisher","first-page":"e01577","DOI":"10.1002\/brb3.1577","volume":"10","author":"J Madhusudhanan","year":"2020","unstructured":"Madhusudhanan J, Suresh G, Devanathan V (2020) Neurodegeneration in type 2 diabetes: Alzheimer\u2019s as a case study. Brain Behav 10(5):e01577. https:\/\/doi.org\/10.1002\/brb3.1577","journal-title":"Brain Behav"},{"issue":"7","key":"3632_CR28","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/ckj\/sfab062","volume":"14","author":"Z Mao","year":"2021","unstructured":"Mao Z, Valluru MK, Ong ACM (2021) Drug repurposing in autosomal dominant polycystic kidney disease: back to the future with pioglitazone. Clin Kidney J 14(7):1715\u20131718. https:\/\/doi.org\/10.1093\/ckj\/sfab062","journal-title":"Clin Kidney J"},{"issue":"4","key":"3632_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/ana.25570","volume":"86","author":"I Martinez-Valbuena","year":"2019","unstructured":"Martinez-Valbuena I, Valenti-Azcarate R, Amat-Villegas I, Riverol M, Marcilla I, de Andrea CE, S\u00e1nchez-Arias JA, Del Mar Carmona-Abellan M, Marti G, Erro ME, Mart\u00ednez-Vila E, Tu\u00f1on MT, Luquin MR (2019) Amylin as a potential link between type 2 diabetes and Alzheimer disease. Ann Neurol 86(4):539\u2013551. https:\/\/doi.org\/10.1002\/ana.25570","journal-title":"Ann Neurol"},{"issue":"2","key":"3632_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1590\/1980-57642015DN92000003","volume":"9","author":"MNPS Matioli","year":"2015","unstructured":"Matioli MNPS, Nitrini R (2015) Mechanisms linking brain insulin resistance to Alzheimer\u2019s disease. Dement Neuropsychol 9(2):96\u2013102. https:\/\/doi.org\/10.1590\/1980-57642015DN92000003","journal-title":"Dement Neuropsychol"},{"issue":"3","key":"3632_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/ilar.47.3.225","volume":"47","author":"AV Matveyenko","year":"2006","unstructured":"Matveyenko AV, Butler PC (2006) Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes. ILAR J 47(3):225\u2013233. https:\/\/doi.org\/10.1093\/ilar.47.3.225","journal-title":"ILAR J"},{"issue":"3","key":"3632_CR32","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2337\/diacare.25.3.517","volume":"25","author":"Y Miyazaki","year":"2002","unstructured":"Miyazaki Y, Matsuda M, DeFronzo RA (2002) Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes. Diabetes Care 25(3):517\u2013523. https:\/\/doi.org\/10.2337\/diacare.25.3.517","journal-title":"Diabetes Care"},{"key":"3632_CR33","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791","journal-title":"J Comput Chem"},{"issue":"3","key":"3632_CR34","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/JOE-14-0202","volume":"222","author":"RW Nelson","year":"2014","unstructured":"Nelson RW, Reusch CE (2014) Animal models of disease: classification and etiology of diabetes in dogs and cats. J Endocrinol 222(3):T1\u2013T9. https:\/\/doi.org\/10.1530\/JOE-14-0202","journal-title":"J Endocrinol"},{"key":"3632_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12987-023-00431-6","volume":"20","author":"V Nguyen","year":"2023","unstructured":"Nguyen V, Thomas P, Pemberton S et al (2023) Central nervous system insulin signaling can influence the rate of insulin influx into brain. Fluids Barriers CNS 20:28. https:\/\/doi.org\/10.1186\/s12987-023-00431-6","journal-title":"Fluids Barriers CNS"},{"issue":"7","key":"3632_CR36","doi-asserted-by":"publisher","first-page":"e68612","DOI":"10.1371\/journal.pone.0068612","volume":"8","author":"P Papadopoulos","year":"2013","unstructured":"Papadopoulos P, Rosa-Neto P, Rochford J, Hamel E (2013) Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer\u2019s disease with combined amyloid-\u03b2 and cerebrovascular pathology. PLoS One 8(7):e68612","journal-title":"PLoS One"},{"issue":"4","key":"3632_CR37","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","volume":"51","author":"R Peila","year":"2002","unstructured":"Peila R, Rodriguez BL, Launer LJ, Honolulu-Asia Aging Study (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study. Diabetes 51(4):1256\u20131262. https:\/\/doi.org\/10.2337\/diabetes.51.4.1256","journal-title":"Diabetes"},{"key":"3632_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fnagi.2019.00178","volume":"11","author":"Q Quan","year":"2019","unstructured":"Quan Q, Qian Y, Li X, Li M (2019) Pioglitazone reduces \u03b2 amyloid levels via inhibition of PPAR\u03b3 phosphorylation in a neuronal model of Alzheimer\u2019s disease. Front Aging Neurosci 11:178. https:\/\/doi.org\/10.3389\/fnagi.2019.00178","journal-title":"Front Aging Neurosci"},{"key":"3632_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fnmol.2020.00035","volume":"13","author":"AF Raimundo","year":"2020","unstructured":"Raimundo AF, Ferreira S, Martins IC, Menezes R (2020) Islet amyloid polypeptide: a partner in crime with A\u03b2 in the pathology of Alzheimer\u2019s disease. Front Mol Neurosci 13:35. https:\/\/doi.org\/10.3389\/fnmol.2020.00035","journal-title":"Front Mol Neurosci"},{"key":"3632_CR40","doi-asserted-by":"publisher","first-page":"44041","DOI":"10.1038\/srep44041","volume":"7","author":"DC Rodriguez Camargo","year":"2017","unstructured":"Rodriguez Camargo DC, Tripsianes K, Buday K, Franko A, G\u00f6bl C, Hartlm\u00fcller C, Sarkar R, Aichler M, Mettenleiter G, Schulz M, B\u00f6ddrich A, Erck C, Martens H, Walch AK, Madl T, Wanker EE, Conrad M, de Angelis MH, Reif B (2017) The redox environment triggers conformational changes and aggregation of hIAPP in type II diabetes. Sci Rep 7:44041. https:\/\/doi.org\/10.1038\/srep44041","journal-title":"Sci Rep"},{"key":"3632_CR41","doi-asserted-by":"publisher","first-page":"666958","DOI":"10.3389\/fnins.2021.666958","volume":"15","author":"AM Saunders","year":"2021","unstructured":"Saunders AM, Burns DK, Gottschalk WK (2021) Reassessment of pioglitazone for Alzheimer\u2019s disease. Front Neurosci. 15:666958. https:\/\/doi.org\/10.3389\/fnins.2021.666958. (Published 2021 Jun 16)","journal-title":"Front Neurosci."},{"key":"3632_CR42","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1038\/s41598-019-40736-x","volume":"9","author":"H Seok","year":"2019","unstructured":"Seok H, Lee M, Shin E et al (2019) Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus. Sci Rep 9:4414. https:\/\/doi.org\/10.1038\/s41598-019-40736-x","journal-title":"Sci Rep"},{"issue":"10","key":"3632_CR43","doi-asserted-by":"publisher","first-page":"e47699","DOI":"10.1371\/journal.pone.0047699","volume":"7","author":"C Slack","year":"2012","unstructured":"Slack C, Foley A, Partridge L (2012) Activation of AMPK by the putative dietary restriction mimetic metformin is insufficient to extend lifespan in Drosophila. PLoS One 7(10):e47699. https:\/\/doi.org\/10.1371\/journal.pone.0047699","journal-title":"PLoS One"},{"issue":"D1","key":"3632_CR44","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, Jensen LJ, Mering CV (2019) STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1):D607\u2013D613. https:\/\/doi.org\/10.1093\/nar\/gky1131","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"3632_CR45","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1006\/jmbi.1999.3422","volume":"295","author":"K Tenidis","year":"2000","unstructured":"Tenidis K, Waldner M, Bernhagen J, Fischle W, Bergmann M, Weber M, Merkle ML, Voelter W, Brunner H, Kapurniotu A (2000) Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J Mol Biol 295(4):1055\u20131071. https:\/\/doi.org\/10.1006\/jmbi.1999.3422","journal-title":"J Mol Biol"},{"issue":"1","key":"3632_CR46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3233\/JAD-160047","volume":"53","author":"N Verma","year":"2016","unstructured":"Verma N, Ly H, Liu M, Chen J, Zhu H, Chow M, Hersh LB, Despa F (2016) Intraneuronal amylin deposition, peroxidative membrane injury and increased IL-1\u03b2 synthesis in brains of Alzheimer\u2019s disease patients with type-2 diabetes and in diabetic HIP rats. J Alzheimers Dis 53(1):259\u2013272. https:\/\/doi.org\/10.3233\/JAD-160047","journal-title":"J Alzheimers Dis"},{"issue":"13","key":"3632_CR47","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","volume":"87","author":"P Westermark","year":"1990","unstructured":"Westermark P, Engstr\u00f6m U, Johnson KH, Westermark GT, Betsholtz C (1990) Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A 87(13):5036\u20135040. https:\/\/doi.org\/10.1073\/pnas.87.13.5036","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"3632_CR48","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1096\/fj.201700431R","volume":"31","author":"N Wijesekara","year":"2017","unstructured":"Wijesekara N, Ahrens R, Sabale M, Wu L, Ha K, Verdile G, Fraser PE (2017) Amyloid-\u03b2 and islet amyloid pathologies link Alzheimer\u2019s disease and type 2 diabetes in a transgenic model. FASEB J 31(12):5409\u20135418. https:\/\/doi.org\/10.1096\/fj.201700431R","journal-title":"FASEB J"},{"issue":"9","key":"3632_CR49","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1110\/ps.036509.108","volume":"17","author":"JJ Wiltzius","year":"2008","unstructured":"Wiltzius JJ, Sievers SA, Sawaya MR, Cascio D, Popov D, Riekel C, Eisenberg D (2008) Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin). Protein Sci 17(9):1467\u20131474. https:\/\/doi.org\/10.1110\/ps.036509.108","journal-title":"Protein Sci"},{"issue":"9","key":"3632_CR50","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G (2019) Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol 15(9):501\u2013518. https:\/\/doi.org\/10.1038\/s41582-019-0228-7","journal-title":"Nat Rev Neurol"},{"key":"3632_CR51","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.3892\/mmr.2017.6342","volume":"15","author":"S Yang","year":"2017","unstructured":"Yang S, Chen Z, Cao M, Li R, Wang Z, Zhang M (2017) Pioglitazone ameliorates A\u03b242 deposition in rats with diet-induced insulin resistance associated with AKT\/GSK3\u03b2 activation. Mol Med Rep 15:2588\u20132594. https:\/\/doi.org\/10.3892\/mmr.2017.6342","journal-title":"Mol Med Rep"},{"issue":"11","key":"3632_CR52","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/s41419-019-2056-5","volume":"10","author":"X Zou","year":"2019","unstructured":"Zou X, Ouyang H, Yu T, Chen X, Pang D, Tang X, Chen C (2019) Preparation of a new type 2 diabetic miniature pig model via the CRISPR\/Cas9 system. Cell Death Dis 10(11):823. https:\/\/doi.org\/10.1038\/s41419-019-2056-5","journal-title":"Cell Death Dis"},{"key":"3632_CR53","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3389\/fphar.2020.00880","volume":"11","author":"X Zou","year":"2020","unstructured":"Zou X, Feng X, Fu Y, Zheng Y, Ma M, Wang C, Zhang Y (2020) Icariin attenuates amyloid-\u03b2 (A\u03b2)-induced neuronal insulin resistance through PTEN downregulation. Front Pharmacol 11:880. https:\/\/doi.org\/10.3389\/fphar.2020.00880","journal-title":"Front Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03632-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03632-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03632-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:17:55Z","timestamp":1744258675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03632-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3632"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03632-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work does not require ethical clearance.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}